Top Markets
Coin of the day
Emcure Pharmaceuticals Ltd. Emcure Pharmaceuticals Ltd.

Emcure Pharmaceuticals Ltd.

EMCURE
Pozycja w akcjach #4302
Emcure Pharmaceuticals Limited is committed to providing high-quality,... Emcure Pharmaceuticals Limited is committed to providing high-quality, cost-effective healthcare solutions to a global market. The company boasts a diverse product lineup spanning numerous medical fields, such as women's health (gynecology), anti-infectives, pain relief, nutritional supplements (vitamins, minerals, and nutrients), hematology, oncology, respiratory treatments, HIV antivirals, gastrointestinal remedies, anti-diabetics, neurological medications, and cardiovascular therapies. Notable brand names under their umbrella include Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym. Founded in 1981, Emcure Pharmaceuticals Limited is headquartered in Pune, India.
Cena akcji
$20.55
Kapitalizacja rynkowa
$3.90B
Zmiana (1 dzień)
0.83%
Zmiana (1 rok)
22.65%
Kraj
IN
Handel Emcure Pharmaceuticals Ltd. (EMCURE)

Kategoria

Historia stopy dywidendy dla Emcure Pharmaceuticals Ltd. (EMCURE)
Stopa dywidendy (TTM) dla Emcure Pharmaceuticals Ltd. (symbol akcji: EMCURE) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Emcure Pharmaceuticals Ltd. (EMCURE) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji